Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that 90% are either highly or partially concerned about the disruption.
A majority 65.8% expressed a high concern over the supply chain disruption due to the coronavirus outbreak, while approximately one-fourth of the respondents were ‘somewhat concerned’.
Less than 10% of the respondents were ‘not concerned’ about the impact. The analysis is based on 1,100 responses, with the ‘concerned’ category including two responses – either ‘extremely concerned’ or ‘very concerned’.
The ‘somewhat concerned’ category clubs the responses of those who expressed a lesser concern by choosing either ‘moderately concerned’ or ‘slightly concerned’.